Friedrich Stölzel

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Uwe Platzbecker, Jan Moritz Middeke, Katja Sockel et al. · The Lancet Oncology · 2018 · 354 citations

Medicine, Hematology, Pharmacology +17

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

Malte von Bonin, Friedrich Stölzel, Anja Goedecke et al. · Bone Marrow Transplantation · 2008 · 302 citations

Medicine, Hematology, Cell Therapy +3

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 289 citations · Full text

Medicine, Immunology, Oncology +7

Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

Stefanie Göllner, Thomas Oellerich, Shuchi Agrawal‐Singh et al. · Nature Medicine · 2016 · 267 citations · Full text

Life Sciences, Molecular Biology, Oncology +14